Back to 
HRT FINANCIAL LP
HRT FINANCIAL LP
BCLI2 quarters
Position history for HRT FINANCIAL LP's holdings in BrainStorm Cell Therapeutics In
No. HRT Financial exited its BCLI (BrainStorm Cell Therapeutics in) position in Q1 2025. Its Q4 2024 13F listed 20,022 shares worth $45,000. HRT Financial first reported BCLI in Q4 2024 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$45,000
Total Shares Change
-20,022
Quarter-by-Quarter History
Other major holders of BCLI: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc.